Kumagai K - Search Results

1

Wavelength index: a predictor of the response to disopyramide in paroxysmal lone atrial fibrillation.

Kumagai K, Gondo N, Matsuo K, Annoura M, Moroe K, Nakashima Y, Hiroki T, Arakawa K. Kumagai K, et al. Cardiology. 1994;85(3-4):184-92. doi: 10.1159/000176674. Cardiology. 1994. PMID: 7987874

2

Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog.

Kumagai K, Yamanouchi Y, Tashiro N, Hiroki T, Arakawa K. Kumagai K, et al. J Am Coll Cardiol. 1990 Aug;16(2):497-501. doi: 10.1016/0735-1097(90)90610-2. J Am Coll Cardiol. 1990. PMID: 2373830 Free article.

3

Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation.

Kumagai K, Matsuo K, Ono M, Yamanouchi Y, Moroe K, Hamasaki N, Arakawa K. Kumagai K, et al. Pacing Clin Electrophysiol. 1993 Feb;16(2):309-16. doi: 10.1111/j.1540-8159.1993.tb01582.x. Pacing Clin Electrophysiol. 1993. PMID: 7680460

4

The best criterion for discrimination between patients with and without paroxysmal atrial fibrillation on signal-averaged electrocardiogram.

Gondo N, Kumagai K, Matsuo K, Ogawa M, Annoura M, Moroe K, Arakawa K. Gondo N, et al. Among authors: kumagai k. Am J Cardiol. 1995 Jan 1;75(1):93-5. doi: 10.1016/s0002-9149(99)80540-2. Am J Cardiol. 1995. PMID: 7801878 No abstract available.

5

Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone.

Gondo N, Kumagai K, Matsuo K, Annoura M, Moroe K, Arakawa K. Gondo N, et al. Among authors: kumagai k. Cardiology. 1994;84(4-5):292-7. doi: 10.1159/000176414. Cardiology. 1994. PMID: 8187115

6

Use of monophasic action potentials to evaluate postpacing T wave changes.

Moroe K, Annoura M, Matsuo K, Yamanouchi Y, Kumagai K, Arakawa K, Hiroki T. Moroe K, et al. Among authors: kumagai k. Cardiology. 1993;83(4):244-9. doi: 10.1159/000175977. Cardiology. 1993. PMID: 8281541

7

Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man.

Matsuo K, Kumagai K, Annoura M, Ideishi M, Arakawa K. Matsuo K, et al. Among authors: kumagai k. Cardiology. 1998;89(2):119-23. doi: 10.1159/000006766. Cardiology. 1998. PMID: 9524012 Clinical Trial.

8

Cholesterol paradox in patients with paroxysmal atrial fibrillation.

Annoura M, Ogawa M, Kumagai K, Zhang B, Saku K, Arakawa K. Annoura M, et al. Among authors: kumagai k. Cardiology. 1999;92(1):21-7. doi: 10.1159/000006942. Cardiology. 1999. PMID: 10640793

9

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation.

Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Nakashima H, et al. Among authors: kumagai k. Circulation. 2000 Jun 6;101(22):2612-7. doi: 10.1161/01.cir.101.22.2612. Circulation. 2000. PMID: 10840013

10

Electrophysiological mechanism of combination therapy with disopyramide and propranolol for paroxysmal atrial fibrillation.

Gondo N, Kumagai K, Yamanouchi Y, Annoura M, Saku K. Gondo N, et al. Among authors: kumagai k. J Cardiol. 2000 Dec;36(6):405-10. J Cardiol. 2000. PMID: 11190584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,647 results

Search Page

Filters